The central banks of Switzerland, South Africa, Japan, Greece, and Belgium are listed on a stock market. Quirky oddities, or worth a closer look?
If you are interested in the inner workings of Undervalued-Shares.com and my plans for next year, then read on.
2024 is bound to see more bids for British companies, sometimes at staggering premia.
Allergies are a 500m patient market, but only 1% of patients are using immunotherapies. If or when that changes, ALK-Abelló will likely lead the market.
Argentina is making headlines for planning radical reforms, but these are already happening in Nigeria. Will Nigerian equities go from value trap to growth play?
Hepsiburada is the Amazon equivalent of Turkey. The New York-listed stock is down 90% since its IPO. Time to buy?